Mechanisms of adeno-associated virus genome encapsidation

Current Gene Therapy

Volumn 5, Issue 3, 2005, Pages 273-284

  Timpe, Jennifer ^a   Bevington, Joyce ^a   Casper, John ^a   Dignam, John D ^a   Trempe, James P ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GENOMIC DNA; PARVOVIRUS VECTOR; PROTEIN VP1; SINGLE STRANDED DNA; VIRUS DNA;

BACULOVIRUS EXPRESSION SYSTEM; DNA MODIFICATION; DNA PACKAGING; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HELPER VIRUS; HUMAN; MUTAGENESIS; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS REPLICATION;

ANIMALS; CAPSID PROTEINS; DEPENDOVIRUS; DNA, VIRAL; GENE THERAPY; GENOME, VIRAL; HUMANS;

ADENO-ASSOCIATED VIRUS; MIRIDAE; PARVOVIRUS;

EID: 21244503122     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566523054065011     Document Type: Review

References (126)

1. Agbandje, M., Kajigaya, S., McKenna, R., Young, N. S., and Rossmann, M. G. (1994). The structure of human parvovirus B19 at 8 A resolution. Virology, 203(1): 106-15.
2. Agbandje-McKenna, M., Llamas-Saiz, A. L., Wang, F., Tattersall, P., and Rossmann, M. G. (1998). Functional implications of the structure of the murine parvovirus, minute virus of mice. Structure, 6(11): 1369-81.
3. Auricchio, A., Kobinger, G., Anand, V., Hildinger, M., O'Connor, E., Maguire, A. M., Wilson, J. M., and Bennett, J. (2001). Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum. Mol. Genet., 10(26): 3075-81.
4. Barouch, D. H., and Harrison, S. C. (1994). Interactions among the major and minor coat proteins of polyomavirus. J. Virol., 68(6): 3982-9.
5. Bartlett, J. S., Wilcher, R., and Samulski, R. J. (2000). Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virology, 74: 2777-2785.
6. Becerra, S. P., Rose, J. A., Hardy, M., Baroudy, B. M., and Anderson, C. W. (1985). Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon. Proc. Natl. Acad. Sci. USA, 82(23): 7919-23.
7. Bleker, S., Sonntag, F., and Kleinschmidt, J. A. (2005). Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity. J. Virol., 79(4): 2528-40.
8. Bloom, M. E., and Young, N. S. (2001). Parvoviruses. 4th ed. In "Parvoviridae: The viruses and their replication." (D. M. Knipe, and P. M. Howley, Eds.), Vol. 2, pp. 2361-2379. 2 vols. Lippincott Williams and Wilkins, Philadelphia.
9. Buning, H., Nicklin, S. A., Perabo, L., Hallek, M., and Baker, A. H. (2003). AAV-based gene transfer. Curr. Opin. Mol. Ther., 5(4): 367-75.
10. Cai, X., Chang, D., Rottinghaus, S., and Consigli, R. A. (1994). Expression and purification of recombinant polyomavirus VP2 protein and its interactions with polyomavirus proteins. J. Virol., 68(11): 7609-13.
11. Carter, B. J. (1990). Adeno-associated virus helper functions. In "Handbook of Parvoviruses," (P. Tijssen, Ed.), Vol. 1, pp. 255-295. 2 vols. CRC Press, Boca Raton, Fla.
12. Carter, B. J. (2004). Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective. Mol. Ther., 10(6): 981-9.
13. Carter, B. J., Burstein, H., and Peluso, R. W. (2004). Adeno-associated virus and AAV vectors for gene delivery. 2nd ed. In "Gene and Cell Therapy: Therapeutic Mechanisms and Strategies." (N. Templeton-Smith, Ed.), pp. 53-101. Dekker, New York.
14. Casal, J. I., Langeveld, J. P., Cortes, E., Schaaper, W. W., van Dijk, E., Vela, C., Kamstrup, S., and Meloen, R. H. (1995). Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J. Virol., 69(11): 7274-7.
15. Caspar, D. L., and Klug, A. (1962). Physical principles in the construction of regular viruses. Cold Spring Harb. Symp. Quant. Biol., 27: 1-24.
16. Cassinotti, P., Weitz, M., and Tratschin, J. D. (1988). Organization of the adeno-associated virus (AAV) capsid gene: mapping of a minor spliced mRNA coding for virus capsid protein 1. Virology, 167(1): 176-84.
17. Chapman, M. S., and Rossmann, M. G. (1993). Structure, sequence, and function correlations among parvoviruses. Virology, 194(2): 491-508.
18. Chapman, M. S., and Rossmann, M. G. (1995). Single-stranded DNA-protein interactions in canine parvovirus. Structure, 3(2): 151-62.
19. Chejanovsky, N., and Carter, B. J. (1989). Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication. Virology, 173: 120-128.
20. Chiorini, J. A., Wiener, S. M., Owens, R. A., Kyostio, S. R., Kotin, R. M., and Safer, B. (1994). Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J. Virol., 68(11): 7448-57.
21. Chipman, P. R., Agbandje-McKenna, M., Kajigaya, S., Brown, K. E., Young, N. S., Baker, T. S., and Rossmann, M. G. (1996). Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor. Proc Natl Acad Sci U S A, 93(15): 7502-6.
22. Chromy, L. R., Pipas, J. M., and Garcea, R. L. (2003). Chaperone-mediated in vitro assembly of Polyomavirus capsids. Proc Natl Acad Sci U S A, 100(18): 10477-82.
23. Clark, K. R., Sferra, T. J., and Johnson, P. R. (1997). Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle. Hum. Gene Ther., 8(6): 659-69.
24. Clinton, G. M., and Hayashi, M. (1976). The parvovirus MVM: a comparison of heavy and light particle infectivity and their density conversion in vitro. Virology, 74(1): 57-63.
25. Collaco, R., Kalman-Maltese, V., Smith, A. D., Dignam, J. D., and Trempe, J. P. (2003). A biochemical characterization of the adeno-associated virus Rep4O helicase. J. Biol. Chem., 278(36): 34011-7.
26. Cotmore, S. F., McKie, V. C., Anderson, L. J., Astell, C. R., and Tattersall, P. (1986). Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol., 60(2): 548-57.
27. Cripe, T. P., Delos, S. E., Estes, P. A., and Garcea, R. L. (1995). In vivo and in vitro association of hsc70 with polyomavirus capsid proteins. J. Virol., 69(12): 7807-13.
28. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., and Chiorini, J. A. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A, 97(7): 3428-32.
29. de la Maza, L. M., and Carter, B. J. (1980). Molecular structure of adeno-associated virus variant DNA. J. Biol. Chem., 255(7): 3194-203.
30. Delos, S. E., Montross, L., Moreland, R. B., and Garcea, R. L. (1993). Expression of the polyomavirus VP2 and VP3 proteins in insect cells: coexpression with the major capsid protein VP1 alters VP2/VP3 subcellular localization. Virology, 194(1): 393-8.
31. Ding, L., Lu, S., and Munshi, N. C. (1997). In vitro packaging of an infectious recombinant adeno-associated virus 2. Gene Ther., 4(11): 1167- 72.
32. Dubielzig, R., King, J. A., Weger, S., Kern, A., and Kleinschmidt, J. A. (1999). Adeno-associated virus type 2 protein interactions: Formation of pre-encapsidation complexes. J. Virology, 73: 8989-8998.
33. Dutheil, N., Yoon-Robarts, M., Ward, P., Henckaerts, E., Skrabanek, L., Berns, K. I., Campagne, F., and Linden, R. M. (2004). Characterization of the mouse adeno-associated virus AAVS1 ortholog. J. Virol., 78(16): 8917-21.
34. Dyall, J., Szabo, P., and Berns, K. I. (1999). Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proc. Natl. Acad. Sci. USA, 96(22): 12849-54.
35. Farr, G. A., and Tattersall, P. (2004). A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection. Virology, 323(2): 243-56.
36. Giraud, C., Winocour, E., and Berns, K. I. (1995). Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol., 69(11): 6917-24.
37. Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deleage, G., and Hallek, M. (1999). Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med., 5(9): 1052-6.
38. Girod, A., Wobus, C. E., Zadori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., and Hallek, M. (2002). The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J. Gen. Virol., 83(Pt 5): 973-8.
39. Grifman, M., Chen, N. N., Gao, G. P., Cathomen, T., Wilson, J. M., and Weitzman, M. D. (1999). Overexpression of cyclin A inhibits augmentation of recombinant adeno-associated virus transduction by the adenovirus E4orf6 protein. J. Virol., 73(12): 10010-9.
40. Halbert, C. L., Allen, J. M., and Miller, A. D. (2001). Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol., 75(14): 6615-24.
41. Hall, M. C., and Matson, S. W. (1999). Helicase motifs: the engine that powers DNA unwinding. Mol. Microbiol., 34(5): 867-77.
42. Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., and Brown, K. E. (2000). Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol., 81(Pt 8): 2077-84.
43. Hermonat, P. L., Labow, M. A., Wright, R., Berns, K. I., and Muzyczka, N. (1984). Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol., 51(2): 329-39.
44. Hermonat, P. L., and Muzyczka, N. (1984). Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc. Natl. Acad. Sci. USA, 81(20): 6466-70.
45. Hong, G., Ward, P., and Berns, K. I. (1992). In vitro replication of adeno-associated virus DNA. Proc. Natl. Acad. Sci. USA, 89(10): 4673-7.
46. Hoque, M., Ishizu, K., Matsumoto, A., Han, S. I., Arisaka, F., Takayama, M., Suzuki, K., Kato, K., Kanda, T., Watanabe, H., and Handa, H. (1999a). Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation. J. Virol., 73(9): 7912-5.
47. Hoque, M., Shimizu, N., Ishizu, K., Yajima, H., Arisaka, F., Suzuki, K., Watanabe, H., and Handa, H. (1999b). Chimeric virus-like particle formation of adeno-associated virus. Biochem. Biophys. Res. Commun., 266(2): 371-6.
48. Hunter, L. A., and Samulski, R. J. (1992). Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells. J. Virol., 66(1): 317-24.
49. James, J. A., Escalante, C. R., Yoon-Robarts, M., Edwards, T. A., Linden, R. M., and Aggarwal, A. K. (2003). Crystal structure of the SF3 helicase from adeno-associated virus type 2. Structure (Camb), 11(8): 1025-35.
50. Kawase, M., Momoeda, M., Young, N. S., and Kajigaya, S. (1995). Modest truncation of the major capsid protein abrogates B19 parvovirus capsid formation. J. Virol., 69(10): 6567-71.
51. King, J. A., Dubielzig, R., Grimm, D., and Kleinschmidt, J. A. (2001). DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids. Embo. J., 20(12): 3282-91.
52. Kotin, R., Siniscalco, M., Samulski, R. J., Zhu, X., Hunter, L., Laughlin, C. A., McLaughlin, S., Muzyczka, N., Rocchi, M., and Berns, K. I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA, 87: 2211-2215.
53. Kronenberg, S., Kleinschmidt, J. A., and Bottcher, B. (2001). Electron cryomicroscopy and image reconstruction of adeno-associated virus type 2 empty capsids. EMBO Rep., 2(11): 997-1002.
54. Langeveld, J. P., Casal, J. I., Cortes, E., van de Wetering, G., Boshuizen, R. S., Schaaper, W. M., Dalsgaard, K., and Meloen, R. H. (1994). Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine, 12(15): 1473-80.
55. Llamas-Saiz, A. L., Agbandje-McKenna, M., Wikoff, W. R., Bratton, J., Tattersall, P., and Rossmann, M. G. (1997). Structure determination of minute virus of mice. Acta. Crystallogr. D. Biol. Crystallogr., 53(Pt 1): 93-102.
56. Lo, W. D., Qu, G., Sferra, T. J., Clark, R., Chen, R., and Johnson, P. R. (1999). Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum. Gene Ther., 10(2): 201-13.
57. Luo, M., Tsao, J., Rossmann, M. G., Basak, S., and Compans, R. W. (1988). Preliminary X-ray crystallographic analysis of canine parvovirus crystals. J. Mol. Biol., 200(1) 209-11.
58. McCarty, D. M., Pereira, D., Zolotukhin, I., Zhou, X., Ryan, J., and Muzyczka, N. (1994). Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J. Virology, 68: 4988-4997.
59. McKenna, R., Olson, N. H., Chipman, P. R., Baker, T. S., Booth, T. F., Christensen, J., Aasted, B., Fox, J. M., Bloom, M. E., Wolfinbarger, J. B., and Agbandje-McKenna, M. (1999). Three-dimensional structure of Aleutian mink disease parvovirus: implications for disease pathogenicity. J. Virol., 73(8): 6882-91.
60. Mendelson, E., Trempe, J. P., and Carter, B. J. (1986). Identification of the trans-acting rep proteins of adeno-associated virus by antibodies to a synthetic oligopeptide. J. Virology, 60: 823-832.
61. Musatov, S., Roberts, J., Pfaff, D., and Kaplitt, M. (2002). A cis-acting element that directs circular adeno-associated virus replication and packaging. J, Virol., 76(24): 12792-802.
62. Muzyczka, N. (1992). Use of adeno-associated virus as a general transduction vector. Curr. Topics Microbiol. Immunol., 158: 97-129.
63. Muzyczka, N., and Berns, K. I. (2001). Parvoviridae: The viruses and their replication. 4th ed. In "Fields Virology" (D. M. Knipe, and P. M. Howley, Eds.), Vol. 2, pp. 2327-2359. 2 vols. Lippincott Williams and Wilkins, Philadelphia.
64. Myers, M. W., and Carter, B. J. (1980). Assembly ofadeno-associated virus. Virology, 102(1): 71-82.
65. Ni, T. H., McDonald, W. F., Zolotukhin, I., Melendy, T., Waga, S., Stillman, B., and Muzyczka, N. (1998). Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J. Virol., 72(4): 2777-87.
66. Ni, T. H., Zhou, X., McCarty, D. M., Zolotukhin, I., and Muzyczka, N. (1994). In vitro replication of adeno-associated virus DNA. J. Virol., 68(2): 1128-38.
67. Nony, P., Chadeuf, G., Tessier, J., Moullier, P., and Salvetti, A. (2003). Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles. J. Virol., 77(1): 776-81.
68. Owens, R. A., Weitzman, M. D., Kyostio, S. R., and Carter, B. J. (1993). Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep protein. J. Virol., 67: 997-1005.
69. Ozawa, K., and Young, N. (1987). Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol., 61(8): 2627-30.
70. Paradiso, P. R. (1981). Infectious process of the parvovirus H-1: correlation of protein content, particle density, and viral infectivity. J. Virol., 39(3): 800-7.
71. Prasad, C. K., Meyers, C., Zhan, D. J., You, H., Chiriva-Internati, M., Mehta, J. L., Liu, Y., and Hermonat, P. L. (2003). The adeno-associated virus major regulatory protein Rep78-c-Jun-DNA motif complex modulates AP-1 activity. Virology, 314(1): 423-31.
72. Prasad, K. M. R., and Trempe, J. P. (1995). The adeno-associated virus Rep78 protein is covalently linked to viral DNA in a pre-formed virion. Virology, 214(360-370).
73. Prasad, K. M. R., Zhou, C., and Trempe, J. P. (1997). Characterization of the Rep78/adeno-associated virus complex. Virology, 229: 183-192.
74. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med., 5: 71-77.
75. Qiu, J., and Brown, K. E. (1999). A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid. Virology, 257(2): 373-82.
76. Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., and Samulski, R. J. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol., 76(2): 791-801.
77. Rabinowitz, J. E., and Samulski, R. J. (2000). Building a better vector: the manipulation of AAV virions. Virology, 278(2): 301-8.
78. Rabinowitz, J. E., and Samulski, R. J. (2002). Vector biophysics: crystal-clear view. Gene Ther., 9(21): 1413-4.
79. Rabinowitz, J. E., Xiao, W., and Samulski, R. J. (1999). Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology, 265(2): 274-85.
80. Recchia, A., parks, R. J., Lamanina, S., Toniatti, C., Pieroni, L., Palombo, F.,Ciliberto, G., Graham, F. L., Corese, R., LaMonica, N., and Collaco, S. (1999). Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Pproc. Natl. Acad. Sci. USA, 96: 2615-2620.
81. Ruffing, M., Heid, H., and Kleinschmidt, J. A. (1994). Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif. J. Gen Virol., 75 (Pt 12): 3385-92.
82. Ruffing, M., Zentgraf, H., and Kleinschmidt, J. A. (1992). Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells. J. Virol., 66(12): 6922-30.
83. Ryan, J., Zolotukhin, S., and Muzyczka, N. (1996). Sequence requirements of Rep68 binding to the adeno-associated virus terminal repeats. J. Virology, 70: 1542-1533.
84. Samulski, R. J., Chen, L. S., and Shenk, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol., 63: 3822-3828.
85. Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., and Engelhardt, J. F. (2000). Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation. J. Virol., 74:: 9184-9196.
86. Senapathy, P., and Carter, B. J. (1984). Molecular cloning of adeno-associated virus variant genomes and generation of infectious virus by recombination in mammalian cells. J. Biol. Chem., 259(7): 4661-6.
87. Senapathy, P., Tratschin, J. D., and Carter, B. J. (1984). Replication of adeno-associated virus DNA. Complementation of naturally occurring rep- mutants by a wild-type genome or an ori- mutant and correction of terminal palindrome deletions. J. Mol. Biol., 179(1): 1-20.
88. Shelling, S. N., and Smith, M. G. (1994). Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin gene. Gene Ther., 1: 165-169.
89. Shi, W., Arnold, G. S., and Bartlett, J. S. (2001). Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum. Gene Ther., 12(14): 1697-711.
90. Smith, R. H., and Kotin, R. M. (1998). The Rep52 gene product of adeno-associated virus is a DNA helicase with 3′-5′ polarity. J. Virology, 72: 4874-4881.
91. Smith, R. H., and Kotin, R. M. (2000). An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA. J. of Virology, 74: 3122-3129.
92. Snyder, R. O., Im, D. S., and Muzyczka, N. (1990). Evidence for covalent attachment of the adeno-associated virus (AAV) Rep protein to the ends of the AAV genome. J. Virol., 64: 6204-6213.
93. Snyder, R. O., Im, D. S., Ni, T., Xiao, X., Samulski, R. J., and Muzyczka, N. (1993). Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J. Virol., 67(10): 6096-104.
94. Srivasatva, A., Lusby, E., and Berns, K. I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virology, 45: 555-564.
95. Stehle, T., and Harrison, S. C. (1996). Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure, 4(2): 183-94.
96. Steinbach, S., Wistuba, A., Bock, T., and Kleinschmidt, J. A. (1997). Assembly of adeno-associated virus type 2 capsids in vitro. J. Gen. Virol .,78(Pt 6): 1453-62.
97. Summerford, C., Bartlett, J. S., and Samulski, R. J. (1999). AlphaV Beta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
98. Summerford, C., and Samulski, R. J. (1998). Membrane-associated heparin sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol., 72: 1438-1445.
99. Tattersall, P., Shatkin, A. J., and Ward, D. C. (1977). Sequence homology between the structural polypeptides of minute virus of mice. J. Mol. Biol., 111(4): 375-94.
100. Tratschin, J. D., Miller, I. L., and Carter, B. J. (1984). Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J. Virol., 51(3): 611-9.
101. Trempe, J. P., and Carter, B. J. (1988). Alternate splicing of adeno-associated virus mRNAs is required for VP1 capsid protein synthesis. J. Virology, 62: 3356-3363.
102. Tsao, J., Chapman, M. S., Agbandje, M., Keller, W., Smith, K., Wu, H., Luo, M., Smith, T. J., Rossmann, M. G., Compans, R. W., and et al. (1991). The three-dimensional structure of canine parvovirus and its functional implications. Science, 251(5000): 1456-64.
103. Tullis, G. E., and Shenk, T. (2000). Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size. J. Virol., 74(24): 11511-21.
104. Urcelay, E., Ward, P., Wiener, S. M., Safer, B., and Kotin, R. M. (1995). Asymetric replication in vitro from a human sequence element is dependent on adeno-associated virus rep protein. J. Virol., 69: 2038-2064.
105. Walker, S., Wonderling, R., and Owens, R. (1997). Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J. Virology, 71: 6996-7004.
106. Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., and Zabner, J. (2004). Structure of adeno-associated virus serotype 5. J. Virol., 78(7): 3361-71.
107. Walton, T. H., Moen, P. T., Jr., Fox, E., and Bodnar, J. W. (1989). Interactions of minute virus of mice and adenovirus with host nucleoli. J. Virol., 63(9): 3651-60.
108. Wang, X. S., Qing, K., Ponnazhagan, S., and Srivastava, A. (1997). Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J. Virol., 71(4): 3077-82.
109. Wang, X. S., and Srivastava, A. (1997). A novel terminal resolution-like site in the adeno-associated virus type 2 genome. J. Virol., 71(2): 1140-6.
110. Ward, P., and Berns, K. I. (1996). In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J. Virol., 70(7): 4495-501.
111. Ward, P., Dean, F.B., O'Donnell, M. E., and Berns, K. I. (1998). Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication. J. Virology, 72: 420-427.
112. Warrington, K. H., Jr., Gorbatyuk, O. S., Harrison, J. K., Opie, S. R., Zolotukhin, S., and Muzyczka, N. (2004). Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J. Virol., 78(12): 6595-609.
113. Weger, S., Wistuba, A., Grimm, D., and Kleinschmidt, J. A. (1997). Control of adeno-associated virus type 2 cap gene expression: relative influence of helper virus, terminal repeats, and Rep proteins. J. Virol., 71(11): 8437-47.
114. Weitzman, M. D., Fisher, K. J., and Wilson, J. M. (1996). Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J. Virol., 70: 1845-1854.
115. Wistuba, A., Kern, A., Weger, S., Grimm, D., and Kleinschmidt, J. A. (1997). Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Prol., 71(2): 1341-52.
116. Wonderling, R. S., Kyostio, S. R. M., and Owens, R. A. (1995). A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activiies. J. Virology, 69: 3542-3548.
117. Wu, H., and Rossmann, M. G. (1993). The canine parvovirus empty capsid structure. J. Mol. Biol., 233(2): 231-44.
118. Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., and Muzyczka, N. (2000). Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol., 74(18): 8635-47.
119. Xiao, W., Chirmule, N., Berta, S. C., McCullough, B., Gao, G., and Wilson, J. M. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol., 73(5): 3994-4003.
120. Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., and Chapman, M. S. (2002). The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci USA, 99(16): 10405-10.
121. Xie, Q., and Chapman, M. S. (1996). Canine parvovirus capsid structure, analyzed at 2.9 A resolution. J. Mol. Biol., 264(3): 497-520.
122. Xie, Q., Somasundaram, T., Bhatia, S., Bu, W., and Chapman, M. S. (2003). Structure determination of adeno-associated virus 2: three complete virus particles per asymmetric unit. Acta. Crystallogr. D. Biol. Crystallogr., 59(Pt 6): 959-70.
123. Yuan, W., and Parrish, C. R. (2001). Canine parvovirus capsid assembly and differences in mammalian and insect cells. Virology, 279(2): 546-57.
124. Zadori, Z., Szelei, J., Lacoste, M. C., Li, Y., Gariepy, S., Raymond, P., Allaire, M., Nabi, I. R., and Tijssen, P. (2001). A viral phospholipase A2 is required for parvovirus infectivity. Dev. Cell, 1(2): 291-302.
125. Zhou, X., and Muzyczka, N. (1998). In vitro packaging of adeno-associated virus DNA. J. Virol., 72(4): 3241-7.
126. Zhou, X., Zolotukhin, I., Im, D.-S., and Muzyczka, N. (1999). Biochemical characterization of adeno-associated virus Rep68 DNA helicase and ATPase activities. J. Virology, 73: 1580-1590.